You are here

Candel Therapeutics

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win

Pharma Voice

Thu, 01/9/25 - 11:09 am

Candel Therapeutics

cancer immunotherapy

prostate cancer

Candel Therapeutics stock up 172% after Phase III prostate cancer success

Clinical Trials Arena

Wed, 12/11/24 - 11:19 am

Candel Therapeutics

clinical trials

prostate cancer

Prostate cancer: Three drug trials to watch

Clinical Trials Arena

Tue, 11/19/24 - 11:22 am

prostate cancer

clinical trials

Candel Therapeutics

Candel wins FDA orphan drug designation for pancreatic cancer drug

Clinical Trials Arena

Sun, 04/14/24 - 01:23 pm

Candel Therapeutics

pancreatic cancer

Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409

Yahoo/Zacks.com

Thu, 12/14/23 - 09:36 am

Candel Therapeutics

pancreatic cancer

Candel Pairs HSV Vectors with Carl June's CAR-T Cells in Solid Tumor Pact

BioSpace

Thu, 10/27/22 - 10:54 am

Candel Therapeutics